Publications by authors named "K C Gouda"

Article Synopsis
  • Bone neoplasms are a group of tumors that mainly affect the appendicular skeleton, especially in adolescents and young adults, and pose significant health risks due to their rapid growth and potential for metastasis.
  • This retrospective study examined 63 patients at a medical college in Western India over 18 months, focusing on age, sex distribution, and tumor types based on WHO classification, finding a mean patient age of 25.8 years and a male-to-female ratio of 1.17:1.
  • The study revealed that benign tumors were more common (57.11%) than malignant ones (42.85%), with giant cell tumors and osteosarcoma being the most frequently identified types respectively.
View Article and Find Full Text PDF

Introduction: Giant cell tumor of bone (GCTB) is a rare yet locally aggressive neoplasm primarily affecting young adults. Its hallmark features include multinucleated osteoclast-type giant cells and mononuclear tumor cells. Treatment with denosumab, an anti-RANK ligand antibody, has shown efficacy, but it alters histomorphology, posing diagnostic challenges.

View Article and Find Full Text PDF

In the first phase of its treatment program, Egypt aimed to treat 250,000 people annually until 2020, thereby reducing the number of viremic patients and limiting hepatitis C virus (HCV) transmission. Egypt strives to eradicate HCV and HCV-associated morbidity by 2030. This study aimed to determine the prevalence of HCV infection among end-stage renal disease patients and the reasons for non-treatment among those offered free medication.

View Article and Find Full Text PDF
Article Synopsis
  • The COVID-19 pandemic has led to serious health and economic impacts, making vaccination a key strategy for controlling the virus.
  • This study evaluates how effective COVID-19 vaccinations have been in reducing cases, hospitalizations, and ICU admissions using data from various countries.
  • Results indicate significant declines in positivity and hospitalization rates following vaccination campaigns, but some countries faced challenges, like rising cases due to the Delta variant, highlighting the need for ongoing vigilance and adaptable strategies.
View Article and Find Full Text PDF

Dialysis therapy has remarkably evolved through the innovation in dialyzers and hemodialysis modalities, enhancing patients' quality of life. The efficacy of dialysis can be determined by measuring the reduction ratio (RR) of middle molecules such as Interleukin-6 (IL-6) and Procalcitonin. In our study, we tested a high-flux dialyzer, BIOPURE (Biorema) 260 HF, with a surface area (SA) of 2.

View Article and Find Full Text PDF